XIAP and hemophagocytic syndrome: X-linked inhibitor of apoptosis (XIAP) deficiency with XIAP/BIRC4 gene mutations is a primary immune deficiency clinically characterized by HLH, inflammatory bowel disease, and splenomegaly (75).